Delivery Order SPE2DB25D7060-SPE2DB25FXSSM
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,697.07 on August 12, 2025, for TYPHIM VI 25 MCG/0.5 ML vials (10 mL units). This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,043.03 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vaccine vials on July 25, 2025, with completion expected by July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,213.67 for TYPHIM VI 25 MCG/0.5 ML vial (10 mL) on August 21, 2025, with completion scheduled for August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML Vial (10ML), a typhoid vaccine product. This firm fixed-price delivery order, valued at $4,316.45, represents a non-competitive set-aside award and is scheduled for completion by July 22, 2025. The product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,388.17 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a firm fixed price, competitively awarded contract with no set-aside designation. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,162.72 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order is non-competitive and utilizes no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply contract. The award represents a child delivery order under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,769.61 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials (10 mL), a typhoid vaccine product. The award, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,632.90 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilized firm fixed-price pricing with no set-aside designation, indicating competitive procurement. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $51,797.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vials (10 ML units). This is a firm fixed-price delivery order with a completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency awarded a delivery order valued at $12,086.06 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price, non-set-aside delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB25FXSSMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,086.06 to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML vials (10 mL quantity) on August 25, 2025, with completion scheduled for August 26, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. As one of the nation's leading pharmaceutical distributors, AmerisourceBergen serves as a critical federal medical procurement vendor supplying brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains to defense and veteran healthcare systems. TYPHIM VI is a typhoid vaccine product, consistent with the company's extensive portfolio of immunizations and medical supplies procured by the Defense Health Agency and other federal healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 8/25/25 |